Agilent Q4 Revenues Inch up 2 Percent; Dako Drives Dx Growth | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies said after the close of the market on Monday that revenues for its Fiscal Year 2012 fourth quarter increased 2 percent year over year.

Total revenues for the three months ended Oct. 31 rose to $1.77 billion from $1.73 billion a year ago, edging out the average analyst estimate of $1.76 billion. Orders during the quarter were flat at $1.75 million.

"The headline for this quarter is that most of our end markets remained soft," Agilent CEO Bill Sullivan said on a conference call after the release of the company's earnings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.